Difficulty: Medium
Average Score: 73%
Practice
Withdrawal of which of the following drugs leads to rebound hypertension:
Correct answer
C
Rationale
In the context of pharmacology of drugs acting on the cardiovascular system, understanding the concept of rebound hypertension is crucial for safe and effective patient care. Rebound hypertension refers to a sudden increase in blood pressure that can occur when certain antihypertensive medications are abruptly discontinued. In this case, the correct answer is option C) Clonidine.
Clonidine is a centrally acting alpha-2 adrenergic agonist that helps lower blood pressure by reducing sympathetic outflow from the central nervous system. When clonidine is suddenly withdrawn, there is a rapid rebound increase in sympathetic activity, leading to a significant rise in blood pressure. This rebound hypertension can be severe and potentially dangerous if not managed appropriately.
Now, let's discuss why the other options are incorrect:
A) Prazosin is an alpha-1 adrenergic receptor antagonist. Withdrawal of prazosin may lead to the reactivation of alpha-1 receptors, but it typically does not result in rebound hypertension.
B) Hydralazine is a direct vasodilator that works by relaxing smooth muscle in blood vessels. Withdrawal of hydralazine may lead to an increase in blood pressure due to the loss of its vasodilatory effects, but it is not associated with rebound hypertension.
D) Captopril is an angiotensin-converting enzyme (ACE) inhibitor. Withdrawal of captopril may lead to a return of baseline blood pressure levels but is not typically associated with rebound hypertension.
Educationally, this question highlights the importance of understanding the mechanisms of action of different antihypertensive drugs and their potential effects upon withdrawal. It reinforces the need for healthcare providers to carefully taper and monitor patients when discontinuing medications to prevent adverse events such as rebound hypertension.
Clonidine is a centrally acting alpha-2 adrenergic agonist that helps lower blood pressure by reducing sympathetic outflow from the central nervous system. When clonidine is suddenly withdrawn, there is a rapid rebound increase in sympathetic activity, leading to a significant rise in blood pressure. This rebound hypertension can be severe and potentially dangerous if not managed appropriately.
Now, let's discuss why the other options are incorrect:
A) Prazosin is an alpha-1 adrenergic receptor antagonist. Withdrawal of prazosin may lead to the reactivation of alpha-1 receptors, but it typically does not result in rebound hypertension.
B) Hydralazine is a direct vasodilator that works by relaxing smooth muscle in blood vessels. Withdrawal of hydralazine may lead to an increase in blood pressure due to the loss of its vasodilatory effects, but it is not associated with rebound hypertension.
D) Captopril is an angiotensin-converting enzyme (ACE) inhibitor. Withdrawal of captopril may lead to a return of baseline blood pressure levels but is not typically associated with rebound hypertension.
Educationally, this question highlights the importance of understanding the mechanisms of action of different antihypertensive drugs and their potential effects upon withdrawal. It reinforces the need for healthcare providers to carefully taper and monitor patients when discontinuing medications to prevent adverse events such as rebound hypertension.